Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Modesti, A.
Right arrow Articles by Modesti, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Modesti, A.
Right arrow Articles by Modesti, P. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:394-401, 2005
© 2005 by the American Diabetes Association, Inc.

Hyperglycemia Activates JAK2 Signaling Pathway in Human Failing Myocytes via Angiotensin II–Mediated Oxidative Stress

Alessandra Modesti1, Iacopo Bertolozzi2, Tania Gamberi1, Matilde Marchetta2, Camilla Lumachi2, Mirella Coppo2, Federico Moroni2, Thomas Toscano3, Gianluca Lucchese3, Gian F. Gensini2, and Pietro A. Modesti2

1 Department of Scienze Biochimiche, University of Florence, Florence, Italy
2 Clinica Medica e Cardiologia, University of Florence, Florence, Italy
3 Institute of Thoracic and Cardiovascular Surgery, University of Siena, Siena, Italy

Hyperglycemia was reported to enhance angiotensin (Ang) II generation in rat cardiomyocytes, and Ang II inhibition reduces cardiovascular morbidity and mortality in diabetic patients. In diabetic patients, the enhanced activation of intracellular pathways related with myocyte hypertrophy and gene expression might enhance the progression of cardiac damage. Therefore, we investigated the effects of glucose on Ang II–mediated activation of Janus-activated kinase (JAK)-2, a tyrosine kinase related with myocyte hypertrophy and cytokine and fibrogenetic growth factor overexpression, in ventricular myocytes isolated from nonfailing human hearts (n = 5) and failing human hearts (n = 8). In nonfailing myocytes, JAK2 phosphorylation was enhanced by Ang II only in the presence of high glucose (25 mmol/l) via Ang II type I (AT1) receptors (+79% vs. normal glucose, P < 0.05). JAK2 activation was prevented by inhibitors of reactive oxygen species (ROS) generation (diphenyleneiodonium [DPI], tiron, and apocynin). In myocytes isolated from failing hearts, JAK2 phosphorylation was enhanced by high glucose alone (+107%, P < 0.05). High glucose–induced JAK2 activation was blunted by both ACE inhibition (100 nmol/l ramipril) and AT1 antagonism (1 µmol/l valsartan), thus revealing that the effects are mediated by autocrine Ang II production. Inhibition of ROS generation also prevented high glucose–induced JAK2 phosphorylation. In conclusion, in human nonfailing myocytes, high glucose allows Ang II to activate JAK2 signaling, whereas in failing myocytes, hyperglycemia alone is able to induce Ang II generation, which in turn activates JAK2 via enhanced oxidative stress.


Address correspondence and reprint requests to Prof. Pietro Amedeo Modesti, MD, PhD, Clinica Medica e Cardiologia, University of Florence, Viale Morgagni 85, 50134 Florence, Italy. E-mail: pamodesti{at}unifi.it

Abbreviations: AGTN, angiotensinogen; Ang, angiotensin; AT1, Ang II type I; AT2, Ang II type II; DMEM, Dulbecco’s minimal essential medium; DPI, diphenyleneiodonium; ERk, extracellular signal–related kinase; JAK, Janus-activated kinase; MAPK, mitogen-activated protein kinase; RAS, renin-angiotensin system; ROS, reactive oxygen species


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
I. Luptak, J. Yan, L. Cui, M. Jain, R. Liao, and R. Tian
Long-Term Effects of Increased Glucose Entry on Mouse Hearts During Normal Aging and Ischemic Stress
Circulation, August 21, 2007; 116(8): 901 - 909.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.